AQR Capital Management LLC Sells 6,588 Shares of Wright Medical Group NV (NASDAQ:WMGI)

AQR Capital Management LLC lessened its position in Wright Medical Group NV (NASDAQ:WMGI) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 103,310 shares of the medical device company’s stock after selling 6,588 shares during the period. AQR Capital Management LLC owned approximately 0.08% of Wright Medical Group worth $2,960,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of the business. Squarepoint Ops LLC bought a new stake in Wright Medical Group in the first quarter valued at approximately $767,000. Maven Securities LTD bought a new stake in Wright Medical Group in the first quarter valued at approximately $2,332,000. Telemetry Investments L.L.C. increased its stake in Wright Medical Group by 66.7% in the first quarter. Telemetry Investments L.L.C. now owns 12,500 shares of the medical device company’s stock valued at $358,000 after purchasing an additional 5,000 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. increased its stake in Wright Medical Group by 58.4% in the first quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 511,958 shares of the medical device company’s stock valued at $14,668,000 after purchasing an additional 188,762 shares in the last quarter. Finally, Gamco Investors INC. ET AL increased its stake in Wright Medical Group by 0.6% in the first quarter. Gamco Investors INC. ET AL now owns 254,626 shares of the medical device company’s stock valued at $7,295,000 after purchasing an additional 1,455 shares in the last quarter. 97.66% of the stock is owned by hedge funds and other institutional investors.

WMGI opened at $29.41 on Wednesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.85 and a quick ratio of 0.56. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -39.74, a P/E/G ratio of 6.11 and a beta of 0.70. The firm’s fifty day moving average price is $29.62 and its two-hundred day moving average price is $29.53. Wright Medical Group NV has a 1 year low of $19.04 and a 1 year high of $30.66.

Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings data on Friday, May 8th. The medical device company reported $0.03 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.05). The firm had revenue of $218.54 million for the quarter, compared to analysts’ expectations of $248.30 million. Wright Medical Group had a positive return on equity of 0.69% and a negative net margin of 10.18%. As a group, equities analysts anticipate that Wright Medical Group NV will post 0.44 EPS for the current year.

Several brokerages have commented on WMGI. ValuEngine downgraded shares of Wright Medical Group from a “buy” rating to a “hold” rating in a research note on Friday, May 1st. Needham & Company LLC cut shares of Wright Medical Group from a “buy” rating to a “hold” rating in a report on Friday, March 13th. BidaskClub lowered shares of Wright Medical Group from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 11th. Finally, TheStreet lowered shares of Wright Medical Group from a “c” rating to a “d+” rating in a research report on Monday, May 18th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $28.05.

Wright Medical Group Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Read More: What are the advantages to having securities held in street name?

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply